Results: 8
Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 119, doi. 10.1007/s40273-022-01225-8
- By:
- Publication type:
- Article
How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 123, doi. 10.1007/s40273-022-01221-y
- By:
- Publication type:
- Article
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 209, doi. 10.1007/s40273-022-01220-z
- By:
- Publication type:
- Article
Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 199, doi. 10.1007/s40273-022-01218-7
- By:
- Publication type:
- Article
The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness Studies.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 139, doi. 10.1007/s40273-022-01217-8
- By:
- Publication type:
- Article
Psychometric Properties of Generic Preference-Weighted Measures for Children and Adolescents: A Systematic Review.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 155, doi. 10.1007/s40273-022-01205-y
- By:
- Publication type:
- Article
Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 175, doi. 10.1007/s40273-022-01188-w
- By:
- Publication type:
- Article
Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 2, p. 187, doi. 10.1007/s40273-022-01157-3
- By:
- Publication type:
- Article